RBC Capital analyst Gregory Renza raised the price target on Perspective Therapeutics Inc (NYSE: CATX) to $16.00 (from $15.00) while ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE